2,2,6,6-Tetramethylpiperidine → (3aR,4S,6aS)-6a-(3-chloro-2,4-difluorophenyl)-4-((trityloxy)methyl)hexahydrofuro[3,4-c]isoxazole

HRID 68370노트

반응식

HRID 68370 반응식
CC1(C)CCCC(C)(C)N1.C([Li])CCC.[Cl:16][C:17]1[C:22]([F:23])=[CH:21][CH:20]=[CH:19][C:18]=1[F:24].[C:25]([O:44][CH2:45][C@@H:46]1[C@@H:53]2[C:49](=[N:50][O:51][CH2:52]2)[CH2:48][O:47]1)([C:38]1[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=1)([C:32]1[CH:37]=[CH:36][CH:35]=[CH:34][CH:33]=1)[C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=1>C1COCC1>[Cl:16][C:17]1[C:22]([F:23])=[C:21]([C@:49]23[CH2:48][O:47][C@H:46]([CH2:45][O:44][C:25]([C:26]4[CH:31]=[CH:30][CH:29]=[CH:28][CH:27]=4)([C:32]4[CH:33]=[CH:34][CH:35]=[CH:36][CH:37]=4)[C:38]4[CH:43]=[CH:42][CH:41]=[CH:40][CH:39]=4)[C@H:53]2[CH2:52][O:51][NH:50]3)[CH:20]=[CH:19][C:18]=1[F:24]

참가 물질

6

반응물 4

HCID 130352,2,6,6-TetramethylpiperidineHCID 142257Benzene, 2-chloro-1,3-difluoro-HCID 57827729HCID 57827729, 화합물HCID 178418339Butyllithium

생성물 1

HCID 86707810(3aR,4S,6aS)-6a-(3-chloro-2,4-difluorophenyl)-4-((trityloxy)methyl)hexahydrofuro[3,4-c]isoxazole수율 34.3%

시약·촉매·용매 1

HCID 8028Tetrahydrofuran용매3회

반응 조건

온도
-78 °C

실험 절차

A stirred solution of 2,2,6,6-tetramethylpiperidine (1.31 mL, 7.78 mmol) in dry THF (20 mL) under nitrogen was cooled in an acetone/dry ice cooling bath. n-Butyl lithium (2.5 M in hexanes, 3.11 mL, 7.78 mmol) was added to this solution such that the internal temperature remained below −75° C. The pale yellow solution was stirred at this temperature for 15 minutes before the addition of a solution of 2-chloro-1,3-difluoro-benzene (0.86 mL, 7.78 mmol) in dry THF (2 mL). The solution was stirred for an additional 30 minutes at −78° C. before the addition of a solution of (3aR,4S)-4-((trityloxy)methyl)-3,3a,4,6-tetrahydrofuro[3,4-c]isoxazole (1.5 g, 3.89 mmol) in dry THF (12 mL). The reaction was stirred at −78° C. After 60 min, the reaction was quenched with saturated aqueous ammonium chloride and then removed from the cooling bath. The mixture was partitioned between EtOAc and water and the layers were separated. The aqueous layer was extracted with EtOAc (3×). The combined organic extracts were washed with brine (1×), then dried over (Na2SO4), filtered and evaporated. The residue was purified by column chromatography (normal phase, 50 g, Biotage SNAP cartridge KP-Sil, 50 mL per min, gradient 5% to 20% to 30% EtOAc in n-hexane) to give the title compound (712 mg). 1H NMR (400 MHz, CDCl3) δ ppm: 3.23-3.35 (m, 2 H) 3.47 (dd, J=9.84, 6.42 Hz, 1 H) 3.86 (dd, J=8.31, 3.79 Hz, 1 H) 3.91 (dd, J=10.33, 1.90 Hz, 1 H) 4.08-4.20 (m, 2 H) 4.22-4.33 (m, 1 H) 6.92-7.00 (m, 1 H) 7.20-7.36 (m, 9 H) 7.41-7.48 (m, 6 H) 7.57-7.67 (m, 1 H).

후처리

  1. customremained below −75° C
  2. customthe reaction was quenched with saturated aqueous ammonium chloride
  3. customremoved from the cooling bath
  4. customThe mixture was partitioned between EtOAc and water
  5. customthe layers were separated
  6. extractionThe aqueous layer was extracted with EtOAc (3×)
  7. washThe combined organic extracts were washed with brine (1×)
  8. dry with materialdried over (Na2SO4)
  9. filtrationfiltered
  10. customevaporated
  11. customThe residue was purified by column chromatography (normal phase, 50 g, Biotage SNAP cartridge KP-Sil, 50 mL per min, gradient 5% to 20% to 30% EtOAc in n-hexane)

출처 및 근거

ORD 기록
ord-4387a6c156e047bfa1152a4b8cf3b449
출처 데이터셋
uspto-grants-2014_09
특허 번호
US08822455B2

반응 노트

불러오는 중…